85 related articles for article (PubMed ID: 11940366)
21. Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning.
Ban K; Cooper AJ; Samuel S; Bhatti A; Patel M; Izumo S; Penninger JM; Backx PH; Oudit GY; Tsushima RG
Circ Res; 2008 Sep; 103(6):643-53. PubMed ID: 18688045
[TBL] [Abstract][Full Text] [Related]
22. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
[TBL] [Abstract][Full Text] [Related]
23. Effect of aflatoxin B1 on phosphoinositide signal transduction pathway during regeneration of liver cells following partial hepatectomy.
Mistry KJ; Krishna M; Bhattacharya RK
Indian J Biochem Biophys; 2001 Aug; 38(4):270-3. PubMed ID: 11811624
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
25. [Phosphatidylinositol kinase: functional roles for PI4-kinase and PIP kinase in signal transduction].
Itoh T; Takenawa T
Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):949-60. PubMed ID: 10396969
[No Abstract] [Full Text] [Related]
26. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.
Zatta AJ; Kin H; Lee G; Wang N; Jiang R; Lust R; Reeves JG; Mykytenko J; Guyton RA; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):315-24. PubMed ID: 16443207
[TBL] [Abstract][Full Text] [Related]
27. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
[TBL] [Abstract][Full Text] [Related]
28. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
[TBL] [Abstract][Full Text] [Related]
29. Ischemic preconditioning promotes a transient, but not sustained translocation of protein kinase C and sensitization of adenylyl cyclase.
Simonis G; Weinbrenner C; Strasser RH
Basic Res Cardiol; 2003 Mar; 98(2):104-13. PubMed ID: 12607132
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidic acid regulates the affinity of the murine phosphatidylinositol 4-phosphate 5-kinase-Ibeta for phosphatidylinositol-4-phosphate.
Jarquin-Pardo M; Fitzpatrick A; Galiano FJ; First EA; Davis JN
J Cell Biochem; 2007 Jan; 100(1):112-28. PubMed ID: 16888807
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin gene related peptide mediates cardioprotection by remote preconditioning.
Wolfrum S; Nienstedt J; Heidbreder M; Schneider K; Dominiak P; Dendorfer A
Regul Pept; 2005 Apr; 127(1-3):217-24. PubMed ID: 15680490
[TBL] [Abstract][Full Text] [Related]
32. [Phosphoinositide 3-kinase/Akt pathway involved in regulation of hypoxia inducible factor 1alpha in hypoxia ischemia brain damage of neonatal rats].
Li L; Qu Y; Mao M; Mu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Sep; 22(9):1102-7. PubMed ID: 18822739
[TBL] [Abstract][Full Text] [Related]
33. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
34. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury.
Vessey DA; Kelley M; Li L; Huang Y; Zhou HZ; Zhu BQ; Karliner JS
Med Sci Monit; 2006 Oct; 12(10):BR318-24. PubMed ID: 17006394
[TBL] [Abstract][Full Text] [Related]
35. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.
Inagaki K; Begley R; Ikeno F; Mochly-Rosen D
Circulation; 2005 Jan; 111(1):44-50. PubMed ID: 15611364
[TBL] [Abstract][Full Text] [Related]
36. Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells.
Singhal RL; Yeh YA; Look KY; Sledge GW; Weber G
Life Sci; 1994; 55(19):1487-92. PubMed ID: 7968216
[TBL] [Abstract][Full Text] [Related]
37. Current issues in the regulation of signal transduction.
Weber G; Prajda N; Yang H; Yeh YA; Shen F; Singhal RL; Herenyiova M; Look KY
Adv Enzyme Regul; 1996; 36():33-55. PubMed ID: 8869739
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylinositol 4-kinase and phosphatidylinositol 4-phosphate 5-kinase assays.
Im YJ; Brglez I; Dieck C; Perera IY; Boss WF
Methods Mol Biol; 2013; 1009():163-74. PubMed ID: 23681532
[TBL] [Abstract][Full Text] [Related]
39. Phosphatidylinositol kinase and phosphatidylinositol 4-phosphate kinase activities in Md 66 insect cell line.
Yadwad VB; Downer RG
Arch Int Physiol Biochim Biophys; 1993; 101(3):203-5. PubMed ID: 7691214
[TBL] [Abstract][Full Text] [Related]
40. Association of protein kinase Cmu with type II phosphatidylinositol 4-kinase and type I phosphatidylinositol-4-phosphate 5-kinase.
Nishikawa K; Toker A; Wong K; Marignani PA; Johannes FJ; Cantley LC
J Biol Chem; 1998 Sep; 273(36):23126-33. PubMed ID: 9722541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
